Citigroup Inc Krystal Biotech, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Citigroup Inc holds 35,084 shares of KRYS stock, worth $5.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,084

Previous 21,210 65.41%

Holding current value

$5.43 Million

Previous $3.9 Million 63.8%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$174.7 - $213.66 $2.42 Million - $2.96 Million	13,874 Added 65.41%	35,084 $6.38 Million
Q2 2024 Aug 12, 2024	SELL	$153.12 - $183.64 $4.73 Million - $5.68 Million	-30,908 Reduced 59.3%	21,210 $3.9 Million
Q1 2024 May 10, 2024	BUY	$108.01 - $179.35 $1.68 Million - $2.79 Million	15,552 Added 42.53%	52,118 $9.27 Million
Q4 2023 Feb 09, 2024	BUY	$96.0 - $128.29 $74,784 - $99,937	779 Added 2.18%	36,566 $4.54 Million
Q3 2023 Nov 09, 2023	BUY	$108.51 - $130.22 $1.46 Million - $1.75 Million	13,423 Added 60.02%	35,787 $4.15 Million
Q2 2023 Aug 10, 2023	SELL	$78.48 - $130.32 $2.21 Million - $3.68 Million	-28,221 Reduced 55.79%	22,364 $2.63 Million
Q1 2023 May 11, 2023	BUY	$72.39 - $84.27 $1.58 Million - $1.84 Million	21,825 Added 75.89%	50,585 $4.05 Million
Q4 2022 Feb 09, 2023	SELL	$63.14 - $79.9 $1.33 Million - $1.68 Million	-21,063 Reduced 42.28%	28,760 $2.28 Million
Q3 2022 Nov 10, 2022	BUY	$64.85 - $82.4 $830,469 - $1.06 Million	12,806 Added 34.59%	49,823 $3.47 Million
Q2 2022 Aug 10, 2022	BUY	$48.93 - $73.47 $1.07 Million - $1.6 Million	21,785 Added 143.02%	37,017 $2.43 Million
Q1 2022 May 12, 2022	SELL	$51.99 - $72.11 $1.02 Million - $1.42 Million	-19,656 Reduced 56.34%	15,232 $1.01 Million
Q4 2021 Feb 10, 2022	BUY	$39.81 - $88.24 $196,104 - $434,670	4,926 Added 16.44%	34,888 $2.44 Million
Q3 2021 Nov 10, 2021	BUY	$52.01 - $71.77 $1.56 Million - $2.15 Million	29,962 New	29,962 $1.56 Million

Others Institutions Holding KRYS

# of Institutions

306

Shares Held

24.2M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $3.97B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account